Penalized likelihood ratio test for a biomarker threshold effect in clinical trials based on generalized linear models
From MaRDI portal
Publication:6059439
DOI10.1002/CJS.11695OpenAlexW4214522216MaRDI QIDQ6059439
Bingshu E. Chen, Unnamed Author, Wenyu Jiang
Publication date: 2 November 2023
Published in: Canadian Journal of Statistics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1002/cjs.11695
clinical trialsgeneralized linear modelspredictive biomarkerpenalized likelihood ratio testbiomarker cutpoint
Cites Work
- A hierarchical Bayes model for biomarker subset effects in clinical trials
- A Bayesian method for risk window estimation with application to HPV vaccine trial
- Optimal rate of convergence for finite mixture models
- Synthesis of variance
- A Modified Likelihood Ratio Test for Homogeneity in Finite Mixture Models
- Non-finite Fisher information and homogeneity: an EM approach
- Hypothesis Testing When a Nuisance Parameter is Present Only Under the Alternative
- Penalized likelihood-ratio test for finite mixture models with multinomial observations
- Inference for Subgroup Analysis With a Structured Logistic-Normal Mixture Model
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Unnamed Item
This page was built for publication: Penalized likelihood ratio test for a biomarker threshold effect in clinical trials based on generalized linear models